Diligence memo · auto-generated · as of July 2, 2026
Ammonett Pharma LLC
Ammonett Pharma LLC looks over-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Ammonett Pharma LLC operates in Pharmaceuticals, based in MIDLOTHIAN.
Sub-sector tags: pharma.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Ammonett Pharma LLC has raised $2.4M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $2.4M on 2018-07-26.
Most recent recorded round closed around 2018-07-26.
Valuation (modeled)modeled
Provath models Ammonett Pharma LLC at approximately $91M (range $1.8M–$712M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 1.50× the median modeled value of Seed Pharmaceuticals companies in 2016–2018 (71 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Last raise 7.9 yr ago; this sector typically re-raises about every 13 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 30% of Pharmaceuticals peers (1613 compared).
Modeled value ranks above 53% of those peers.
Closest niche peers: Chase Therapeutics Corp, Acura Pharmaceuticals, Inc, Paragon Biosciences Skyline Capital, LLC, Phoenix PharmaLabs Inc, Saghmos Therapeutics, Inc..
Peoplefiled
4 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
Modeled above niche peers — valuation risk on entry.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.